Bicalutamide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Ani Pharmaceuticals, Inc.. The primary component is Bicalutamide.
| Product ID | 62559-890_08296ef3-1710-4975-8454-56e6731b4067 |
| NDC | 62559-890 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Bicalutamide |
| Generic Name | Bicalutamide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-10-26 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020498 |
| Labeler Name | ANI Pharmaceuticals, Inc. |
| Substance Name | BICALUTAMIDE |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-10-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0093-0220 | Bicalutamide | Bicalutamide |
| 0904-6019 | Bicalutamide | Bicalutamide |
| 16714-571 | Bicalutamide | bicalutamide |
| 16714-816 | Bicalutamide | Bicalutamide |
| 16729-023 | Bicalutamide | Bicalutamide |
| 47335-485 | bicalutamide | bicalutamide |
| 60429-177 | Bicalutamide | Bicalutamide |
| 60505-2642 | Bicalutamide | Bicalutamide |
| 62559-890 | Bicalutamide | Bicalutamide |
| 63629-8308 | Bicalutamide | Bicalutamide |
| 63672-0005 | Bicalutamide | Bicalutamide |
| 65841-613 | Bicalutamide | Bicalutamide |
| 67253-191 | bicalutamide | bicalutamide |
| 68382-224 | Bicalutamide | Bicalutamide |
| 70518-2993 | Bicalutamide | Bicalutamide |
| 71205-577 | Bicalutamide | Bicalutamide |
| 71335-0765 | Bicalutamide | Bicalutamide |
| 0310-0705 | CASODEX | Bicalutamide |
| 62559-680 | CASODEX | Bicalutamide |